Categories: Budget

Budget reaction from Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics

New Delhi, February 01, 2022: Reduction of sur-charge  to 12% on Long Term capital Gains is welcome step.

Unintentional errors in Income Tax can be corrected by filing updated return within 2 years from the end of Assessment year – This is a positive change.

Department to wait before filing an appeal in higher court in respect of disputes of similar nature with regard to interpretation of law , in case cases of similar nature are pending in Supreme court / other courts – This is also a very good step .

Significant increase in Capital expenditure allocation by almost 35% will probably spur economic growth and create jobs.

Extension of emergency credit guarantee scheme till 31/03/2023 is a step in the right direction .

National Digital Health Ecosystem , National Tele Mental Health Programme – Very god initiatives if implemented well .

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

8 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago